AndrewsG. A.RootS. W.KermanH. D.BigelowR. R.: Intracavitary colloidal radiogold in treatment of effusions caused by malignant neoplasms. Ann. Surg.137 (1953), 375.
2.
BeierwaltesW. H.JohnsonP. H.SolariA. J.: Clinical use of radioisotopes. First edition, p. 257. W. B. Saunders, Philadelphia—London 1957.
3.
BraestrupC. B.: Radiation protection. First edition, p. 247. Charles C. Thomas, Springfield, Ill.1958.
4.
DennisJ. M.WorkmanJ. B.BauerR. E.: Radioactive colloidal gold in the control of malignant effusions. Amer. J. Roentgenol.75 (1956), 1124.
5.
DiamondH. D.: The medical management of cancer. First edition, p. 159. Grune & Stratton, New York—London 1958.
6.
ElkinsH. B.KeettelW. C.: Radioactive gold in the treatment of ovarian carcinoma. Amer. J. Roentgenol.75 (1956), 1117.
7.
FriesB.KottmeierH.-L.WalinderG.: Treatment of peritoneal carcinosis with colloidal Au198 in combination with polyphloretin phosphate. Acta radiol.52 (1959), 81.
8.
HansenP. B.HaugA.: Radioaktivt guld (Au198) anvendt terapeutisk ved maligne lidelser i pleura og peritoneum (Danish). Ugeskr. Læg.121 (1959), 1641.
9.
HansenP. B.HaugA.: Treatment of pleural and peritoneal carcinomatous effusions with radioactive gold (1956–1959). Acta radiol.53 (1960), 321.
10.
HarbeH.: Über Nebenerscheinungen bei gynäkologischer Radiogold Therapie. Fortschritt. Röntgenstr.85 (1956), 610.
11.
JørgsholmB.: Treatment of advanced cancer by TEM and by TEM combined with irradiation and prednisone. Acta radiol. (1959). Suppl. No. 188, p. 130.
12.
KarlstedtK.: Personal communication.
13.
KlingermanM. M.HabifD. V.: The use of radioactive gold in the treatment of effusions due to carcinomatosis of the pleura and peritoneum. Amer. J. Roentgenol.74 (1955), 651.
14.
Low-BeerB. V. A.: The clinical use of radioactive isotopes. First edition, p. 399. Charles C. Thomas, Springfield, Ill.1950.
15.
MolinB.: Intrapleural behandling av carcinomatos med Trietylentiofosforamid (TSPA) (Swedish). Paper read before the Meeting of the Scandinavian Association of Medical Radiologists, Bergen 1960.
16.
MüllerJ. H.: Über die Verwendung von künstlichen radioaktiven Isotopen zur Erzielung von lokalisierten biologischen Strahlenwirkungen. Experientia1 (1945), 199.
17.
MüllerJ. H.: Weitere Entwicklung der Therapie von Peritonealcarcinosen bei Ovariecarcinom mit künstlicher Radioaktivität (Au198). Gynaecologia129 (1950), 289.
18.
SealS. H.CrosignsniS.ValvassoriG. et coll.: The treatment of malignant effusions with radioactive colloidal gold (Au198). Amer. J. Obstet. Gynec.75 (1958), 1027.